187 related articles for article (PubMed ID: 23501106)
1. Interaction of the phospholipid scramblase 1 with HIV-1 Tat results in the repression of Tat-dependent transcription.
Kusano S; Eizuru Y
Biochem Biophys Res Commun; 2013 Apr; 433(4):438-44. PubMed ID: 23501106
[TBL] [Abstract][Full Text] [Related]
2. Human phospholipid scramblase 1 interacts with and regulates transactivation of HTLV-1 Tax.
Kusano S; Eizuru Y
Virology; 2012 Oct; 432(2):343-52. PubMed ID: 22789739
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription.
Endo-Munoz L; Warby T; Harrich D; McMillan NA
Virol J; 2005 Feb; 2():17. PubMed ID: 15737233
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus-1 Nef suppresses Hsp70-mediated Tat activation.
Sugiyama R; Naganuma H; Nishitsuji H; Takaku H
FEBS Lett; 2011 Nov; 585(21):3367-71. PubMed ID: 21970979
[TBL] [Abstract][Full Text] [Related]
5. Short communication: a single step assay for rapid evaluation of inhibitors targeting HIV type 1 Tat-mediated long terminal repeat transactivation.
Chande AG; Baba M; Mukhopadhyaya R
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):902-6. PubMed ID: 21878060
[TBL] [Abstract][Full Text] [Related]
6. HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation.
Zhang HS; Ruan Z; Sang WW
J Cell Physiol; 2011 Dec; 226(12):3385-91. PubMed ID: 21344388
[TBL] [Abstract][Full Text] [Related]
7. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 infection induces acetylation of NPM1 that facilitates Tat localization and enhances viral transactivation.
Gadad SS; Rajan RE; Senapati P; Chatterjee S; Shandilya J; Dash PK; Ranga U; Kundu TK
J Mol Biol; 2011 Jul; 410(5):997-1007. PubMed ID: 21763502
[TBL] [Abstract][Full Text] [Related]
9. Luman, a new partner of HIV-1 TMgp41, interferes with Tat-mediated transcription of the HIV-1 LTR.
Blot G; Lopez-Vergès S; Treand C; Kubat NJ; Delcroix-Genête D; Emiliani S; Benarous R; Berlioz-Torrent C
J Mol Biol; 2006 Dec; 364(5):1034-47. PubMed ID: 17054986
[TBL] [Abstract][Full Text] [Related]
10. SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase.
Zhang HS; Wu MR
Virus Res; 2009 Dec; 146(1-2):51-7. PubMed ID: 19720090
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD(+)-dependent SIRT1 activity.
Zhang HS; Zhou Y; Wu MR; Zhou HS; Xu F
Life Sci; 2009 Sep; 85(13-14):484-9. PubMed ID: 19664641
[TBL] [Abstract][Full Text] [Related]
12. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators.
Madore SJ; Cullen BR
Virology; 1995 Feb; 206(2):1150-4. PubMed ID: 7856090
[TBL] [Abstract][Full Text] [Related]
13. Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation.
Zhang HS; Li HY; Zhou Y; Wu MR; Zhou HS
Free Radic Biol Med; 2009 Aug; 47(3):261-8. PubMed ID: 19409485
[TBL] [Abstract][Full Text] [Related]
14. EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway.
Zhang HS; Wu TC; Sang WW; Ruan Z
Life Sci; 2012 May; 90(19-20):747-54. PubMed ID: 22480519
[TBL] [Abstract][Full Text] [Related]
15. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
de Arellano ER; Alcamí J; López M; Soriano V; Holguín A
Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
[TBL] [Abstract][Full Text] [Related]
16. Interaction of phospholipid scramblase 1 with the Epstein-Barr virus protein BZLF1 represses BZLF1-mediated lytic gene transcription.
Kusano S; Ikeda M
J Biol Chem; 2019 Oct; 294(41):15104-15116. PubMed ID: 31434743
[TBL] [Abstract][Full Text] [Related]
17. Cyclin T1 stabilizes expression levels of HIV-1 Tat in cells.
Imai K; Asamitsu K; Victoriano AF; Cueno ME; Fujinaga K; Okamoto T
FEBS J; 2009 Dec; 276(23):7124-33. PubMed ID: 20064163
[TBL] [Abstract][Full Text] [Related]
18. FoxO4 negatively controls Tat-mediated HIV-1 transcription through the post-transcriptional suppression of Tat encoding mRNA.
Oteiza A; Mechti N
J Gen Virol; 2017 Jul; 98(7):1864-1878. PubMed ID: 28699853
[TBL] [Abstract][Full Text] [Related]
19. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
20. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]